Ads
related to: atopic dermatitis- Before & After Photos
See the Before and After of What
A Treatment Option Can Do For You.
- Eczema Causes
Learn More About The Causes
Of Eczema (Atopic Dermatitis).
- What Is Eczema?
Find Important Facts & Information
To Understand Atopic Dermatitis.
- Atopic Dermatitis
Learn About Causes, Symptoms,
& An Oral Treatment Option.
- Sign Up for Info
Get Updates, Answers, and Resources
For Treatment Support
- Patient Support
Sign Up For Tools And Support
For Eczema (Atopic Dermatitis).
- Before & After Photos
Search results
Rapid Rx Quiz: New Agents for Treating Atopic Dermatitis
Medscape· 1 day agoTopical corticosteroids were the initial treatment option for atopic dermatitis (AD) beginning in...
J&J to acquire experimental eczema drug for $1.25B
NJBIZ· 2 hours agoJohnson & Johnson plans to pay $1.25 billion for the rights to an experimental eczema treatment. The New Brunswick-based pharma giant announced the...
Tapinarof Cream Effective For AD, Down to Age 2 Years
Medscape· 1 day agoResults from two phase 3 trials showed that topical tapinarof, once a day, was effective and safe in patients with atopic dermatitis as young as 2 years old.
J&J scoops up another atopic dermatitis antibody in $1.25B Numab rights deal
FierceBiotech· 2 days agoNot satisfied with just one new immunology deal this month, Johnson & Johnson is plunking down $1.25...
Parental e-Cigarette Use May Increase AD Risk in Children
Medscape· 3 days agoParental e-cigarette use was associated with an increased risk for pediatric atopic dermatitis in a...
J&J (JNJ) to Buy Rights to Novel Atopic Dermatitis Candidate
Zacks via Yahoo Finance· 1 day agoJ&J (JNJ) is set to acquire Yellow Jersey Therapeutics, which holds NM26 rights, from Numab's...
...Owned Subsidiary Yellow Jersey Therapeutics Including Rights to NM26, a Bi-Specific Antibody for...
Morningstar· 2 days agoYJT comprises all assets relating to NM26, an investigational first-in-class bi-specific antibody for the treatment of atopic dermatitis (AD) set to advance ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 2 days ago- New study follows completion of first-in-human Phase 1b trial in atopic dermatitis patients, in which selectION observed safety and tolerability of si ...
Dupilumab: Future Treatment for Pediatric Alopecia Areata?
Medscape· 1 day agoChildren with concomitant atopic dermatitis (AD) and alopecia areata (AA) who were treated with...
J&J acquires experimental skin disorder drug for $1.25 billion
Reuters· 2 days ago, opens new tab on Tuesday agreed to acquire the rights to an experimental skin disorder treatment...
Ads
related to: atopic dermatitis